The digital transformation of both government and business in all sectors can bring huge operational advantages, increasing flexibility for employees and creating a competitive advantage for entities that digitise--but the more data there is to manage, the more vulnerable that very data is to attack. This discussion with former GCHQ director and BlueVoyant Europe Chairman Robert Hannigan will focus on the threats posed by the collection, storage and analysis of big data, and what can be done to mitigate these risks.

Innovations like blockchain and the Internet of Things may still be evolving and reshaping the corporate landscape, but the threats related to these breakthrough technologies are already commonplace. This panel examines the risks that corporate cyber-defence teams must work to mitigate before investing and implementing new technologies.

As cryptocurrencies continue to grow in popularity as an asset class, the likelihood that governments and regulators will step in to protect consumers and prevent systemic risk is on the rise. While regulation would give these markets legitimacy, they could also prove limiting. How will cryptocurrency markets react if the exchanges are soon regulated, and what effect would reclassification as a financial asset have?

AI is radically disrupting the pharmaceutical industry, as the availability of data transforms drug development and streamlines the supply chain and production process. We speak to executives in pharma to find out how they're collaborating with AI startups to revolutionise drug research, development and production.